Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2002 8
2003 13
2004 13
2005 12
2006 10
2007 16
2008 27
2009 14
2010 29
2011 36
2012 48
2013 57
2014 63
2015 43
2016 59
2017 49
2018 56
2019 69
2020 62
2021 92
2022 66
2023 74
2024 29

Text availability

Article attribute

Article type

Publication date

Search Results

828 results

Results by year

Filters applied: . Clear all
Page 1
Similar efficacy of ibrutinib arms across ALPINE and ELEVATE-RR trials in relapsed/refractory chronic lymphocytic leukemia: a matching-adjusted indirect comparison.
Shadman M, Tedeschi A, Mohseninejad L, Yang K, Lamanna N, Xu S, Cohen A, Challagulla S, Xue M, Williams R, O'Brien SM, Brown JR, Tam C. Shadman M, et al. Among authors: brown jr. Blood Cancer J. 2024 May 2;14(1):77. doi: 10.1038/s41408-024-01044-4. Blood Cancer J. 2024. PMID: 38697986 No abstract available.
Transitions of care: An aerodigestive provider assessment survey.
Brown JN, Blumhardt S, Lostak B, Acorda D, Weissbrod PA, Henningfeld JK, Gavini S, Anani AO, Brown A, Raol NP, Sterling L, Jiwani A, Bedwell JR, Ongkasuwan J. Brown JN, et al. Int J Pediatr Otorhinolaryngol. 2024 Apr 5;180:111933. doi: 10.1016/j.ijporl.2024.111933. Online ahead of print. Int J Pediatr Otorhinolaryngol. 2024. PMID: 38692234
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2024.
Wierda WG, Brown J, Abramson JS, Awan F, Bilgrami SF, Bociek G, Brander D, Cortese M, Cripe L, Davis RS, Eradat H, Fakhri B, Fletcher CD, Gaballa S, Hamid MS, Hill B, Kaesberg P, Kahl B, Kamdar M, Kipps TJ, Ma S, Mosse C, Nakhoda S, Parikh S, Schorr A, Schuster S, Seshadri M, Siddiqi T, Stephens DM, Thompson M, Ujjani C, Valdez R, Wagner-Johnston N, Woyach JA, Sundar H, Dwyer M. Wierda WG, et al. Among authors: brown j. J Natl Compr Canc Netw. 2024 Apr;22(3):175-204. doi: 10.6004/jnccn.2024.0018. J Natl Compr Canc Netw. 2024. PMID: 38626800
Evidence-based post-ban research to inform effective menthol cigarette bans in the United States and other jurisdictions.
Erinoso O, Brown JL, Glasser AM, Gravely S, Fong GT, Chung-Hall J, Kyriakos CN, Liber AC, Craig LV, White AM, Rose SW, Smiley SL, Zeller M, Leischow S, Ayo-Yusuf O, Cohen JE, Ashley D; Tobacco Regulatory Science Writing Group. Erinoso O, et al. Among authors: brown jl. Nicotine Tob Res. 2024 Apr 13:ntae082. doi: 10.1093/ntr/ntae082. Online ahead of print. Nicotine Tob Res. 2024. PMID: 38613422 No abstract available.
Final 3-Year Study Outcomes from the Evaluation of the Zilver Vena Venous Stent for the Treatment of Symptomatic Iliofemoral Venous Outflow Obstruction (VIVO Clinical Study).
Comerota AJ, Gagne P, Brown JA, Segbefia E, Hofmann LV; VIVO Clinical Study Investigators. Comerota AJ, et al. Among authors: brown ja. J Vasc Interv Radiol. 2024 Mar 12:S1051-0443(24)00209-4. doi: 10.1016/j.jvir.2024.02.025. Online ahead of print. J Vasc Interv Radiol. 2024. PMID: 38484910 Free article.
828 results